PH16669A - Erythromycylamine 11,12-carbonate and derivatives thereof - Google Patents

Erythromycylamine 11,12-carbonate and derivatives thereof

Info

Publication number
PH16669A
PH16669A PH25449A PH25449A PH16669A PH 16669 A PH16669 A PH 16669A PH 25449 A PH25449 A PH 25449A PH 25449 A PH25449 A PH 25449A PH 16669 A PH16669 A PH 16669A
Authority
PH
Philippines
Prior art keywords
erythromycylamine
carbonate
derivatives
Prior art date
Application number
PH25449A
Other languages
English (en)
Inventor
Frank Christian Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH16669A publication Critical patent/PH16669A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PH25449A 1980-04-01 1981-03-30 Erythromycylamine 11,12-carbonate and derivatives thereof PH16669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/136,197 US4283527A (en) 1980-04-01 1980-04-01 Erythromycylamine 11,12-carbonate and derivatives thereof

Publications (1)

Publication Number Publication Date
PH16669A true PH16669A (en) 1983-12-13

Family

ID=22471781

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25449A PH16669A (en) 1980-04-01 1981-03-30 Erythromycylamine 11,12-carbonate and derivatives thereof

Country Status (11)

Country Link
US (1) US4283527A (de)
EP (1) EP0037241B1 (de)
JP (1) JPS56154496A (de)
AR (1) AR226885A1 (de)
CA (1) CA1151160A (de)
DE (1) DE3165498D1 (de)
DK (1) DK152214C (de)
ES (1) ES8202561A1 (de)
GR (1) GR74812B (de)
IE (1) IE51481B1 (de)
PH (1) PH16669A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DK90788A (da) * 1987-02-24 1988-08-25 Beecham Group Plc Erythromycinderivater
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
PL76937B1 (pl) * 1971-05-06 1977-07-30 Instytut Przemysłu Farmaceutycznego Sposób wytwarzania cyklicznych węglanów estrów erytromycynowych kwasów jednokarboksylowych
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives

Also Published As

Publication number Publication date
DK152214C (da) 1988-08-08
US4283527A (en) 1981-08-11
EP0037241B1 (de) 1984-08-15
DE3165498D1 (en) 1984-09-20
IE51481B1 (en) 1987-01-07
GR74812B (de) 1984-07-12
JPS56154496A (en) 1981-11-30
AR226885A1 (es) 1982-08-31
DK144781A (da) 1981-10-02
ES500939A0 (es) 1982-02-01
IE810714L (en) 1981-10-01
EP0037241A1 (de) 1981-10-07
JPS6219437B2 (de) 1987-04-28
CA1151160A (en) 1983-08-02
DK152214B (da) 1988-02-08
ES8202561A1 (es) 1982-02-01

Similar Documents

Publication Publication Date Title
EP0050460A3 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
GB2102806B (en) 26,26,26,27,27,27-hexafluoro-1 ,25-dihydroxy-cholecalciferol and derivatives thereof
IL61930A0 (en) 25-hydroxy-26,26,26,27,27,27-hexafluoroch-olecalciferol and derivatives thereof
GB2106902B (en) 2,2-disubstituted-ethylamines
IL64774A (en) Hexahydro-trans and tetrahydropyridoindole derivatives
GB2048254B (en) 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
JPS56150027A (en) 2,3-dichloro-2-trifluoromethyl-1,1,1,3,4,4,5,5,5- nonafluoropentane and its manufacture
JPS56139435A (en) 3,3-dimethyl-1-phenoxy-butan-2-ol and manufacture
PH16669A (en) Erythromycylamine 11,12-carbonate and derivatives thereof
GB2125788B (en) 17,18-dehydro-apovincaminol
ZW7782A1 (en) 2,4-disubstituted-5-thiazolecarboxylic acids and derivatives
GB2075982B (en) 1-3-dihydroxy-27-nor-cholesta-5-en and 5,7-dien-25-one
DE3266355D1 (en) Octahydrotetracyanoquinodimethane and derivatives thereof
ZA825796B (en) 1,2-dithiol-3-ylideneammonium derivatives
JPS5728051A (en) 1,4-dihydropyridines and manufacture
GB2084578B (en) Coumarinyl-7 and 3,4-benzo coumarinyl-7 derivatives
JPS57108036A (en) 2,2-dimethylcyclobutanones and manufacture
PH18356A (en) Phenoxyphenyl-tetrahydro-1,3,5-thidiazin-4-ones
JPS5775943A (en) 3,3-dimethyl-1-fluoro-1-phenoxy-2-butanones or -butanols and manufacture thereof
JPS57188530A (en) 1,1-diphenylalk-1-ene and manufacture
ZA823838B (en) 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranone or-dibenzofuranol derivatives
DE3368640D1 (en) 5,2',3',4',4",6"-hexadeoxykanamycin and its 1-n-acylated derivative
GB2090829B (en) 16-amino-pgf2 and derivatives
GB2095247B (en) N-(b-amenoethyl)-4-hydroxy-2,2,6,6-tetramethyl-piperidene and derivatives thereof
DE3169834D1 (en) N,n-diacylaminoperfluoroalkanesulfonanilides and derivatives thereof

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 13